Login / Signup

Safety of Ceasing Aspirin Used Without a Clinical Indication After Age 70 Years: A Subgroup Analysis of the ASPREE Randomized Trial.

Mark Raymond NelsonGalina PolekhinaRobyn L WoodsChristopher M ReidAndrew M TonkinRory WolfeAnne M MurrayBrenda KirpachMichael E ErnstJessica E LockeryRaj C ShahNigel P StocksSuzanne G OrchardZhen Zhou
Published in: Annals of internal medicine (2022)
Keyphrases
  • low dose
  • cardiovascular events
  • antiplatelet therapy
  • type diabetes
  • cardiovascular disease
  • randomized controlled trial
  • phase iii